bioAffinity Technologies (BIAF) News Today $1.23 -0.05 (-3.54%) (As of 01:50 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period bioAffinity Technologies Reports Strong Q3 GrowthNovember 15, 2024 | markets.businessinsider.combioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024November 14, 2024 | finanznachrichten.debioAffinity Technologies Announces Award of Japanese Patent for CyPath® LungOctober 31, 2024 | finance.yahoo.comBioAffinity Technologies announces closing of $2.6M registered direct offeringOctober 22, 2024 | markets.businessinsider.comWallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private PlacementOctober 21, 2024 | prnewswire.combioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private PlacementOctober 21, 2024 | finance.yahoo.combioAffinity Technologies (NASDAQ:BIAF) Stock Quotes, Forecast and News SummaryOctober 19, 2024 | benzinga.combioAffinity VP contributes to new cytometry guidelinesOctober 19, 2024 | uk.investing.combioAffinity's CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry GuidelinesOctober 19, 2024 | stockhouse.combioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private PlacementOctober 19, 2024 | businesswire.comBioAffinity Technologies Down 25% on Stock Sale, Warrant Private PlacementOctober 19, 2024 | marketwatch.combioAffinity Technologies Inc BIAFOctober 19, 2024 | morningstar.comWallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private PlacementOctober 18, 2024 | prnewswire.comLung cancer spit test fast-tracks a San Antonio biotech company for growthOctober 12, 2024 | msn.combioAffinity Technologies Names J. Michael Edwards as Chief Financial OfficerOctober 10, 2024 | finance.yahoo.combioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath ® Lung TestOctober 9, 2024 | businesswire.comWallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionAugust 5, 2024 | prnewswire.comWallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 MillionAugust 2, 2024 | prnewswire.comMaxim Group Initiates Coverage of bioAffinity Technologies (BIAF) with Buy RecommendationJuly 24, 2024 | msn.combioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsJune 12, 2024 | businesswire.comBIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024May 15, 2024 | msn.combioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesMay 15, 2024 | businesswire.combioAffinity Technologies News UpdateMay 2, 2024 | businesswire.combioAffinity Technologies appoints VP to enhance diagnosticsApril 26, 2024 | investing.combioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthApril 24, 2024 | businesswire.combioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningApril 9, 2024 | finance.yahoo.combioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningApril 9, 2024 | businesswire.combioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 8, 2024 | finance.yahoo.comWallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 8, 2024 | finance.yahoo.comNasdaq Gains 100 Points; Campbell Soup Earnings Top ViewsMarch 6, 2024 | msn.comBioAffinity Technologies Shares Plummet After Stock SaleMarch 6, 2024 | marketwatch.comWhy BioAffinity Technologies (BIAF) Shares Are Down 50%March 6, 2024 | msn.comBioAffinity Technologies to raise $2.5M from stock offering and private placementMarch 6, 2024 | msn.comWallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 6, 2024 | finance.yahoo.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | marketbeat.combioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementMarch 6, 2024 | businesswire.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 6, 2024 | marketbeat.comTrading was temporarily halted for "BIAF" at 09:03 AM with a stated reason of "LULD pause."March 5, 2024 | marketbeat.comHere's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn SituationMarch 1, 2024 | finance.yahoo.combioAffinity Technologies News UpdateFebruary 21, 2024 | finance.yahoo.combioAffinity Technologies News UpdateFebruary 21, 2024 | businesswire.comMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeFebruary 6, 2024 | finance.yahoo.combioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerJanuary 23, 2024 | finance.yahoo.combioAffinity Technologies In the NewsJanuary 8, 2024 | finance.yahoo.comBioAffinity Shares Rise on Addition to Government Pay ScheduleNovember 30, 2023 | marketwatch.comCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024November 30, 2023 | finance.yahoo.combioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer ScreeningNovember 15, 2023 | finance.yahoo.combioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 14, 2023 | finance.yahoo.comSA biotech hire to bolster national expansionNovember 6, 2023 | bizjournals.com Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! BIAF Media Mentions By Week BIAF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIAF News Sentiment▼-0.660.47▲Average Medical News Sentiment BIAF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIAF Articles This Week▼30▲BIAF Articles Average Week Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies YY Group News Today Mobiquity Technologies News Today PSQ News Today Vacasa News Today Forian News Today BGSF News Today Heritage Global News Today Luna Innovations News Today Aeries Technology News Today SPAR Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIAF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts